Treatment issues and core needle breast biopsy: Clinical context

American Journal of Roentgenology

Volumn 171, Issue 1, 1998, Pages 41-49

  Gundry, Kathleen R ^a   Berg, Wendie A ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CANCER; BREAST HYPERPLASIA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAMMOGRAPHY; MASTECTOMY; NEEDLE BIOPSY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0031832074     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.171.1.9648760     Document Type: Review

References (76)

1. Jackson VP, Bassett LW. Stereotactic fine-needle aspiration biopsy for nonpalpable breast lesions. AJR 1990;154:1196-1197
2. Masood S. Occult breast lesions and aspiration biopsy: a new challenge (editorial). Diagn Cytopathol 1993;9:613-614
3. Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology 1997;202:849-854
4. Rubin E, Dempsey PJ, Pile NS, et al. Needle-localization biopsy of the breast: impact of a selective core needle biopsy program on yield. Radiology 1995;195:627-631
5. Sickles EA. Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient. Radiology 1994;192:439-442
6. Sickles EA, Parker SH. Appropriate role of core breast biopsy in the management of probably benign lesions (editorial). Radiology 1993;188:315
7. Brenner RJ, Fajardo L, Fisher PR, et al. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. AJR 1996;166:341-346
8. Liberman L, Dershaw DD, Rosen PP, Cohen MA, Hann LE, Abramson AF. Stereotaxic core biopsy of impalpable spiculated breast masses. AJR 1995;165:551-554
9. Evans WP. Core biopsy: guns and needles. In: Dershaw D, ed. Interventional breast procedures. New York: Churchill Livingston, 1996:55-87
10. Fenoglio ME, Gallagher JQ, Joy N, Higgins A, Miller B, Ratzer ER. Stereotactic core breast biopsy versus needle localization breast biopsy: the effect of initial diagnostic modality on surgical therapy in patients with breast cancer. Minim Invasive Ther Allied Technol 1997;6:225-227
11. Yim JH, Barton P, Weber B, et al. Mammographically detected breast cancer: benefits of stereotactic core versus wire localization biopsy. Ann Surg 1996;223:688-700
12. Liberman L, LaTrenta LR, Dershaw DD, et al. Impact of core biopsy on the surgical management of impalpable breast cancer. AJR 1997; 168:495-499
13. Tabar L, Dean PB. Teaching atlas of mammography, 2nd ed. Stuttgart: Thieme, 1985:96-101
14. Douglas-Jones AG, Pace DP. Pathology of R4 spiculated lesions in the breast screening programme. Histopathology 1996;30:214-220
15. Frouge C, Tristant H, Guinebretiere J-M, et al. Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology 1995;195:623-625
16. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 1993;23:225-231
17. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: DeVita VT, Hellstem S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 4th ed., vol. 1. Philadelphia: Lippincott, 1993:1264-1332
18. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy with radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-1586
19. Rosen PP, Braun DW, Kinne DE. The clinical significance of pre-invasive breast carcinoma. Cancer 1980;46:919-925
20. Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 1997;202:843-847
21. Jackman RJ, Burbank F, Parker SH, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14g directional vacuum-assisted biopsy. Radiology 1997;204:485-488
22. Jackman RJ, Burbank FH, Parker SH, et al. Atypical ductal hyperplasia diagnosed by 11-gauge, directional, vacuum assisted breast biopsy: how often is carcinoma found at surgery? (abstr). Radiology 1997;205(P):325
23. Berg WA, Krebs TL, Campassi C, Magder LS, Sun C-CJ. Evaluation of 14g and 11g directional vacuum biopsy and 14g biopsy guns in a breast parenchymal model. Radiology 1997;205:203-208
24. Burbank F, Forcier N. Tissue marking clip for stereotactic breast biopsy: initial placement accuracy, long-term stability, and usefulness as a guide for wire localization. Radiology 1997;205: 407-415
25. Homer MJ. Mammographic interpretation: a practical approach. New York: McGraw-Hill, 1997:45
26. Halverson KJ, Taylor ME, Perez CA, et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 1994;17:461-466
27. Whitten TM, Fraser HR, Christensen WN, Turk PS. Axillary lymph node metastases in stage T1a breast cancer: a pathologic review of 82 patients. Am Surg 1997;63:144-149
28. Adler LP, Faulhaber PF, Schnur KC, Al-kasi NL, Shenk RR. Axillary lymph node metastases: screening with (F-18)2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997;203:323-327
29. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 1997;349:1864-1867
30. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350
31. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822
32. Liberman L, Hann LE, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Mammographic findings after stereotactic 14-gauge vacuum biopsy. Radiology 1997;203:343-347
33. Mussurakis S, Buckley DL, Horsman A. A prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997;203:317-321
34. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3184 consecutive cases. Radiology 1991;179:463-468
35. Berg WA. When is core breast biopsy or fine-needle aspiration not enough? (editorial). Radiology 1996;198:313-315
36. Liberman L, Dershaw DD, Glassman J, et al. Analysis of cancers not diagnosed at stereotaxic core breast biopsy. Radiology 1997;203:151-157
37. Liberman L, LaTrenta LR, VanZee KJ, Morris EA, Abramson AF, Dershaw DD. Stereotactic core biopsy of calcifications highly suggestive of malignancy. Radiology 1997;203:673-677
38. Colbassani HJ Jr, Feller WF, Cigtay OS, Chun B. Mammographic and pathologic correlation of microcalcification in disease of the breast. Surg Gynecol Obstet 1982;155:689-696
39. Prorok JJ, Trostle DR, Scarlato M, Rachman R. Excisional breast biopsy and roentgenographic examination for mammographically detected microcalcification. Am J Surg 1983;145:684-686
40. Roses DF, Harris MN, Gorstein F, Gumport SL. Biopsy for microcalcification detected by mammography. Surgery 1980;87:248-252
41. Homer MJ, Safaii H, Smith TJ, Marchant DJ. The relationship of mammographic microcalcification to malignancy: radiologic-pathologic correlation. AJR 1989;153:1187-1189
42. Stomper P, Cholewinski S, Penetrante R, Harlos J, Tsangaris T. Atypical hyperplasia: frequency and mammographic and pathologic relationships in excisional biopsies guided with mammography and clinical examination. Radiology 1993; 189:667-671
43. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994;193:91-95
44. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR 1995;164:1111-1113
45. Fowble B. Intraductal noninvasive breast cancer: a comparison of three local treatments. Oncology 1989;3:51-64
46. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short term treatment failures. Cancer 1982;50:1309-1314
47. Schwartz GF, Patchesfsky AS, Feig SA, Shaber GS, Schwartz AB. Multicentricity of non-palpable breast cancer. Cancer 1980;45:2913-2916
48. Dershaw DD, Abramson AF, Kinne DW. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 1989;170:411-415
49. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994;193:359-364
50. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:1232-1239
51. Giordano JM, Klopp CT. Lobular carcinoma in situ: incidence and treatment. Cancer 1973; 31:105-109
52. Pope TL Jr, Fechner RE, Wilhelm MC, Wanebo HJ, de Paredes ES. Lobular carcinoma in situ of the breast: mammographic features. Radiology 1988;168:63-66
53. Beute BJ, Kalisher L, Hutter RVP. Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. AJR 1991;157:257-265
54. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978;42:737-769
55. Gump FE. Lobular carcinoma in situ: pathology and treatment. Surg Clin North Am 1990;70:873-883
56. Rosen PP, Senie R, Schottenfeld D, Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 1979;189:377-382
57. Carter D, Smith RL. Carcinoma in situ of the breast. Cancer 1977;40:1189-1193
58. Shah JP, Rosen PP, Robbins GF. Pitfalls of local excision in the treatment of carcinoma of the breast. Surg Gynecol Obstet 1973;136:721-725
59. Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer 1975;35:739-747
60. Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. In: Sommers S, Rosen P, eds. Pathology annual. New York: Appleton-Century-Crofts, 1981:83-102
61. Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 1985; 56:979-990
62. Hartsell WF, Recine DC, Griem KL, Cobleigh MA, Witt TR, Murthy AK. Should multicentric disease be an absolute contraindication to the use of breast-conserving therapy? Int J Radiat Oncol Biol Phys 1994;30:49-53
63. Liberman L, Dershaw DD, Rosen PP, Morris EA, Cohen MA, Abramson AF. Core needle biopsy of synchronous ipsilateral breast lesions: impact on treatment. AJR 1996;166:1429-1432
64. Rosenblatt R, Fineberg SA, Sparano JA, Kaleya RN. Stereotactic core needle biopsy of multiple sites in the breast: efficacy and effect on patient care. Radiology 1996;201:67-70
65. Donovan AJ. Bilateral breast cancer. Surg Clin North Am 1990;70:1141-1149
66. Roubidoux MA, Helvie MA, Wilson TE, Lai NE, Paramagul C. Women with breast cancer: histologic findings in the contralateral breast. Radiology 1997;203:691-694
67. Healey EA, Osteen RT, Schnitt SJ, et al. Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer? Int J Radiat Oncol Biol Phys 1989;17:1217-1221
68. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-118
69. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74:1746-1751
70. Bonadonna G. From adjuvant to neo-adjuvant chemotherapy in high risk breast cancer: the experience of the Milan Cancer Institute. Int J Cancer 1993;55:1-4
71. Jacquillat C, Weil M, Baillet F, et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990;66:119-129
72. Vinnicombe SJ, MacVicar AD, Guy RL, et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathological correlation. Radiology 1996;198:333-340
73. Pace ME, Berg WA. The role of large core needle biopsy in locally advanced breast cancer. Md Med J 1997;46:419-423
74. Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 1996;198:327-332
75. Rebner M, Pennes DR, Adler DD, Helvie MA, Lichter AS. Breast microcalcifications after lumpectomy and radiation therapy. Radiology 1989;170:691-693
76. Stomper PC, Recht A, Berenberg AL, Jochelson MS, Harris JR. Mammographic detection of recurrent cancer in the irradiated breast. AJR 1986;148:39-43